Collar Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$221K Hold
1,750
0.13% 69
2026
Q1
$244K Hold
1,750
0.16% 66
2025
Q4
$215K Buy
+1,750
New +$213K 0.14% 70
2025
Q2
Sell
-1,800
Closed -$202K 70
2025
Q1
$202K Buy
+1,800
New +$186K 0.18% 66

Other funds holding GILD

Collar Capital Management's GILD Position: Q2 2026 in Review

Collar Capital Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 1,750 shares worth $221K. The position accounts for 0.13% of the portfolio, ranked #69.

Collar Capital Management first reported a position in GILD in Q1 2025 and has held it in 4 quarters since. The position peaked at $244K in Q1 2026. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Collar Capital Management held 1,750 shares of Gilead Sciences worth $221K as of Q2 2026.
  • Collar Capital Management left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.13% of Collar Capital Management's portfolio in Q2 2026, its #69 holding.
  • Collar Capital Management first reported a position in Gilead Sciences in Q1 2025 and has held it in 4 quarters since.
  • Collar Capital Management's Gilead Sciences position peaked at $244K in Q1 2026.
  • 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Collar Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.